Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 18

1.

Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter?

Grignon O, Montassier E, Corvec S, Lepelletier D, Hardouin JB, Caillon J, Batard E; EDBAC Study Group.

Eur J Clin Microbiol Infect Dis. 2015 Mar;34(3):571-7. doi: 10.1007/s10096-014-2264-y. Epub 2014 Oct 23.

PMID:
25339200
2.

The Escherichia coli phylogenetic group B2 with integrons prevails in childhood recurrent urinary tract infections.

Kõljalg S, Truusalu K, Stsepetova J, Pai K, Vainumäe I, Sepp E, Mikelsaar M.

APMIS. 2014 May;122(5):452-8. doi: 10.1111/apm.12167. Epub 2013 Sep 11.

PMID:
24033434
3.

FPIN's clinical inquiries: antibiotic prophylaxis to prevent recurrent UTI in children.

Lo V, Wah Y, Maggio L.

Am Fam Physician. 2011 Jul 15;84(2):3-4. No abstract available.

4.

[National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].

Wagenlehner FM, Schmiemann G, Hoyme U, Fünfstück R, Hummers-Pradier E, Kaase M, Kniehl E, Selbach I, Sester U, Vahlensieck W, Watermann D, Naber KG.

Urologe A. 2011 Feb;50(2):153-69. doi: 10.1007/s00120-011-2512-z. Review. German.

PMID:
21312083
5.

Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients.

Rafat C, Vimont S, Ancel PY, Xu-Dubois YC, Mesnard L, Ouali N, Denis M, Vandewalle A, Rondeau E, Hertig A.

Transpl Infect Dis. 2011 Aug;13(4):344-52. doi: 10.1111/j.1399-3062.2011.00602.x. Epub 2011 Feb 7.

PMID:
21299776
6.

Acute pyelonephritis: clinical characteristics and the role of the surgical treatment.

Lee DG, Jeon SH, Lee CH, Lee SJ, Kim JI, Chang SG.

J Korean Med Sci. 2009 Apr;24(2):296-301. doi: 10.3346/jkms.2009.24.2.296. Epub 2009 Apr 20.

7.

Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.

Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ; EMERGEncy ID NET Study Group.

Clin Infect Dis. 2008 Nov 1;47(9):1150-8. doi: 10.1086/592250.

9.

Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.

Moreno E, Prats G, Sabaté M, Pérez T, Johnson JR, Andreu A.

J Antimicrob Chemother. 2006 Feb;57(2):204-11. Epub 2006 Jan 3.

10.

Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections.

Manges AR, Perdreau-Remington F, Solberg O, Riley LW.

J Infect. 2006 Jul;53(1):25-9. Epub 2005 Nov 2.

PMID:
16269177
11.

Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis.

Manges AR, Dietrich PS, Riley LW.

Clin Infect Dis. 2004 Feb 1;38(3):329-34. Epub 2004 Jan 6.

12.

Addressing antibiotic resistance.

Gupta K.

Dis Mon. 2003 Feb;49(2):99-110. Review.

PMID:
12601340
13.

Addressing antibiotic resistance.

Gupta K.

Am J Med. 2002 Jul 8;113 Suppl 1A:29S-34S. Review.

PMID:
12113869
14.

[Urinary tract infections and antibiotic resistance].

Malinverni R.

Ther Umsch. 2002 Jan;59(1):31-5. German.

PMID:
11851044
15.

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.

Gupta K, Hooton TM, Stamm WE.

Ann Intern Med. 2001 Jul 3;135(1):41-50. Review.

PMID:
11434731
16.

Antibiotic prophylaxis in children with relapsing urinary tract infections: review.

Mangiarotti P, Pizzini C, Fanos V.

J Chemother. 2000 Apr;12(2):115-23. Review.

PMID:
10789549
17.

[Present status of the treatment of urological infections].

Ukhin AV.

Antibiot Med Biotekhnol. 1985 May;30(5):384-91. Review. Russian. No abstract available.

PMID:
3896135
18.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk